These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38252989)

  • 1. 3,5-Disubstituted-thiazolidine-2,4-dione hybrids as antidiabetic agents: Design, synthesis, in-vitro and In vivo evaluation.
    Singh G; Singh R; Monga V; Mehan S
    Eur J Med Chem; 2024 Feb; 266():116139. PubMed ID: 38252989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives.
    Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA
    J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives.
    Hussain F; Khan Z; Jan MS; Ahmad S; Ahmad A; Rashid U; Ullah F; Ayaz M; Sadiq A
    Bioorg Chem; 2019 Oct; 91():103128. PubMed ID: 31369977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus.
    Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A
    Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations.
    Zahra S; Zaib S; Khan I
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129241. PubMed ID: 38199537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress.
    Kothari M; Kannan K; Sahadevan R; Sadhukhan S
    Int J Biol Macromol; 2024 Apr; 263(Pt 1):130175. PubMed ID: 38360242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
    Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
    Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidine-2,4-dione derivatives as potential α-glucosidase inhibitors: Synthesis, inhibitory activity, binding interaction and hypoglycemic activity.
    Li M; Sun J; Liang B; Min X; Hu J; Wu R; Xu X
    Bioorg Chem; 2024 Mar; 144():107177. PubMed ID: 38335756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of indole derivatives containing thiazolidine-2,4-dione as α-glucosidase inhibitors with antidiabetic activity.
    Hu C; Liang B; Sun J; Li J; Xiong Z; Wang SH; Xuetao X
    Eur J Med Chem; 2024 Jan; 264():115957. PubMed ID: 38029465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiabetic potential of Catechu via assays for α-glucosidase, α-amylase, and glucose uptake in adipocytes.
    Zhang K; Chen XL; Zhao X; Ni JY; Wang HL; Han M; Zhang YM
    J Ethnopharmacol; 2022 Jun; 291():115118. PubMed ID: 35202712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis,
    Singh G; Singh R; Monga V; Mehan S
    RSC Med Chem; 2024 Aug; 15(8):2826-2854. PubMed ID: 39149094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of α-glucosidase and α-amylase inhibitory effects of phenoxy chalcones and molecular modeling studies.
    Kurşun-Aktar BS; Adem Ş; Tatar-Yilmaz G; Hameed ZAH; Oruç-Emre EE
    J Mol Recognit; 2023 Nov; 36(11):e3061. PubMed ID: 37720970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies.
    Farzaneh E; Mohammadi M; Raymand P; Noori M; Golestani S; Ranjbar S; Ghasemi Y; Mohammadi-Khanaposhtani M; Asadi M; Nasli Esfahani E; Rastegar H; Larijani B; Mahdavi M; Taslimi P
    Bioorg Chem; 2024 Apr; 145():107207. PubMed ID: 38402795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological, toxicological and molecular docking evaluations of isoxazoline-thiazolidine-2,4-dione analogues as new class of anti-hyperglycemic agents.
    Fettach S; Thari FZ; Hafidi Z; Karrouchi K; Bouathmany K; Cherrah Y; El Achouri M; Benbacer L; El Mzibri M; Sefrioui H; Bougrin K; Faouzi MEA
    J Biomol Struct Dyn; 2023 Feb; 41(3):1072-1084. PubMed ID: 34957934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Docking and Dynamics Simulation of Natural Compounds from Betel Leaves (
    Ahmed S; Ali MC; Ruma RA; Mahmud S; Paul GK; Saleh MA; Alshahrani MM; Obaidullah AJ; Biswas SK; Rahman MM; Rahman MM; Islam MR
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889399
    [No Abstract]   [Full Text] [Related]  

  • 17. Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors.
    Ritu ; Sharma P; Gupta GD; Asati V
    Bioorg Chem; 2023 Oct; 139():106750. PubMed ID: 37499530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of α-glucosidase and α-amylase by herbal compounds for the treatment of type 2 diabetes: A validation of in silico reverse docking with in vitro enzyme assays.
    Tolmie M; Bester MJ; Apostolides Z
    J Diabetes; 2021 Oct; 13(10):779-791. PubMed ID: 33550683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Prenylchalconaringenins and Prenylnaringenins as Antidiabetic Agents: α-Glucosidase and α-Amylase Inhibition and in Vivo Antihyperglycemic and Antihyperlipidemic Effects.
    Sun H; Wang D; Song X; Zhang Y; Ding W; Peng X; Zhang X; Li Y; Ma Y; Wang R; Yu P
    J Agric Food Chem; 2017 Mar; 65(8):1574-1581. PubMed ID: 28132506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indenoquinoxaline-phenylacrylohydrazide hybrids as promising drug candidates for the treatment of type 2 diabetes: In vitro and in silico evaluation of enzyme inhibition and antioxidant activity.
    Hameed S; Saleem F; Özil M; Baltaş N; Salar U; Ashraf S; Ul-Haq Z; Taha M; Khan KM
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):129517. PubMed ID: 38266833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.